Caribou Current Deferred Revenue from 2010 to 2024
| CRBU Stock | USD 1.98 0.02 1.02% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 2.8 M | Current Value 4.9 M | Quarterly Volatility 3.1 M |
Check Caribou Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caribou Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 202.7 K, Net Interest Income of 119.7 K or Interest Income of 126.5 K, as well as many indicators such as Price To Sales Ratio of 11.65, Dividend Yield of 0.0 or PTB Ratio of 1.09. Caribou financial statements analysis is a perfect complement when working with Caribou Biosciences Valuation or Volatility modules.
Caribou | Current Deferred Revenue |
Latest Caribou Biosciences' Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Caribou Biosciences over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Caribou Biosciences' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caribou Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Caribou Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 2,249,220 | |
| Geometric Mean | 1,138,557 | |
| Coefficient Of Variation | 138.61 | |
| Mean Deviation | 2,321,389 | |
| Median | 717,000 | |
| Standard Deviation | 3,117,725 | |
| Sample Variance | 9.7T | |
| Range | 9.8M | |
| R-Value | 0.61 | |
| Mean Square Error | 6.6T | |
| R-Squared | 0.37 | |
| Significance | 0.02 | |
| Slope | 423,497 | |
| Total Sum of Squares | 136.1T |
Caribou Current Deferred Revenue History
About Caribou Biosciences Financial Statements
Caribou Biosciences shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Caribou Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Caribou Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Caribou Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2.8 M | 4.9 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.